# Vitalant – FDA Inspection, Jun 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/vitalant/da5e8ab1-63da-412f-85c8-74271469ac14
Source feed: FDA_Inspections

> FDA inspection 1321216 of Vitalant, June 09, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321216
- Company Name: Vitalant
- Inspection Date: 2026-06-09
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1178692 - 2022-08-10
- FDA Inspection 1063370 - 2018-07-25
- FDA Inspection 971653 - 2016-04-20
- FDA Inspection 878175 - 2014-04-30
- FDA Inspection 779317 - 2012-03-09

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)

Company: https://www.keypedia.com/companies/vitalant/b9b4314c-fc2b-424f-b2a5-b643bc2bd996

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
